← Who reports today · Health Care
ZTS earnings date & Q2 2026 results · Zoetis
US GAAP · $M · vs Q2 2025 · quarter ended 06/30/2026 · reported 08/06/2026
Zoetis Inc. (/zō-EH-tis/), headquartered in Parsippany, New Jersey, is the largest producer of medicine and vaccinations for pets and livestock worldwide. · Text: Wikipedia, CC BY-SA 4.0, abridged
More about the company
The company's products include antiparasitics, vaccines, products that relieve itch, anti-infectives, products that alleviate pain, animal health diagnostics, as well as hormones, cardiopulmonary, topical and oral hygiene therapeutics, central nervous system drugs, diuretics, antiemetic, euthanasia, and hepato-digestive products. The company has operations in over 50 countries.
When is ZTS’s next earnings date?
Tuesday, November 3, 2026estimated
Expected around Nov 3 — based on last year’s report on Nov 4, 2025. We have not yet seen the company's announcement of the date.
How we estimate
The estimate is the date of the same-quarter report a year ago, per the company’s SEC filing, moved forward 52 weeks (same weekday). Companies usually keep the same week; the date will be replaced once ZTS announces it.
Same quarter a year ago (ended September 30, 2025): revenue $2.4B, EPS (GAAP) $1.63
How we calculate
Year-ago figures are GAAP, from the company's SEC filings (XBRL); EPS is diluted.
What time does ZTS report? Usually before market open: the last 4 results releases reached the SEC at 7:06 am, 7:05 am, 7:04 am, 7:06 am ET.
Last report: Aug 6, 2026 (Q2 2026) — broken down in the Sankey chart below. Dates: company announcements; past dates and times — SEC 8-K filings. Who else reports this week →
All figures in $M.
Revenue
$2,468
−0.2%
Operating income
$922
−4.7%
37.4% margin
Net income
$691
−4.8%
$1.65/sh · 28.0% margin
Verdict: revenue fell 0.2% y/y to $2.47B, operating margin 37.4% vs 39.1%, net income $691M (−4.8% y/y).
Guidance for adjusted diluted EPS was revised to $6.15 - $6.25.
Source and notation
Source: Zoetis press release, 8-K EX-99.1 of 08/06/2026 (SEC EDGAR). Every figure was matched against the income statement in the release and checked against SEC XBRL. Operating income is calculated (revenue less costs and operating expenses): the release does not report it.
Open the chart as a PNG image ↗ · for sharing and presentations · free to reuse, CC BY 4.0
ZTS earnings history: past report dates
| Aug 6, 2026 Thu | 7:06 ambefore market open | Jun 30, 2026 | $2.5B−0% y/y | $1.65+1% y/y |
| May 7, 2026 Thu | 7:05 ambefore market open | Mar 31, 2026 | $2.3B+3% y/y | $1.42+6% y/y |
| Feb 12, 2026 Thu | 7:04 ambefore market open | Dec 31, 2025 | ≈$2.4B+3% y/y | ≈$1.42+10% y/y |
| Nov 4, 2025 Tue | 7:06 ambefore market open | Sep 30, 2025 | $2.4B+1% y/y | $1.63+9% y/y |
| Aug 5, 2025 Tue | 7:05 ambefore market open | Jun 30, 2025 | $2.5B+5% y/y | $1.63+19% y/y |
| May 6, 2025 Tue | 7:03 ambefore market open | Mar 31, 2025 | $2.2B+0% y/y | $1.34+2% y/y |
| Feb 13, 2025 Thu | 7:07 ambefore market open | Dec 31, 2024 | ≈$2.3B+5% y/y | ≈$1.29+13% y/y |
| Nov 4, 2024 Mon | 7:04 ambefore market open | Sep 30, 2024 | $2.4B+11% y/y | $1.50+16% y/y |
| Aug 6, 2024 Tue | 7:05 ambefore market open | Jun 30, 2024 | $2.4B+8% y/y | $1.37−6% y/y |
| May 2, 2024 Thu | 7:04 ambefore market open | Mar 31, 2024 | $2.2B+10% y/y | $1.31+10% y/y |
| Feb 13, 2024 Tue | 7:06 ambefore market open | Dec 31, 2023 | ≈$2.2B+8% y/y | ≈$1.14+16% y/y |
| Nov 2, 2023 Thu | 7:05 ambefore market open | Sep 30, 2023 | $2.2B+7% y/y | $1.29+14% y/y |
| Aug 8, 2023 Tue | 7:04 ambefore market open | Jun 30, 2023 | $2.2B+6% y/y | $1.45+29% y/y |
| May 4, 2023 Thu | 7:06 ambefore market open | Mar 31, 2023 | $2.0B+1% y/y | $1.19−6% y/y |
| Feb 14, 2023 Tue | 7:05 ambefore market open | Dec 31, 2022 | ≈$2.0B+4% y/y | ≈$0.98+13% y/y |
| Nov 3, 2022 Thu | 7:08 ambefore market open | Sep 30, 2022 | $2.0B+1% y/y | $1.13−3% y/y |
| Aug 4, 2022 Thu | 7:05 ambefore market open | Jun 30, 2022 | $2.1B+5% y/y | $1.12+5% y/y |
| May 5, 2022 Thu | 7:05 ambefore market open | Mar 31, 2022 | $2.0B+6% y/y | $1.26+8% y/y |
| Feb 15, 2022 Tue | 7:05 ambefore market open | Dec 31, 2021 | ≈$2.0B+9% y/y | ≈$0.87+16% y/y |
| Nov 4, 2021 Thu | 7:04 ambefore market open | Sep 30, 2021 | $2.0B+11% y/y | $1.16+16% y/y |
| Aug 5, 2021 Thu | 7:07 ambefore market open | Jun 30, 2021 | $1.9B+26% y/y | $1.07+35% y/y |
| May 6, 2021 Thu | 7:05 ambefore market open | Mar 31, 2021 | $1.9B+22% y/y | $1.17+33% y/y |
| Feb 16, 2021 Tue | 7:03 ambefore market open | Dec 31, 2020 | ≈$1.8B+8% y/y | ≈$0.75−6% y/y |
| Nov 5, 2020 Thu | 7:06 ambefore market open | Sep 30, 2020 | $1.8B+13% y/y | $1.00+11% y/y |
| Aug 6, 2020 Thu | 7:05 ambefore market open | Jun 30, 2020 | $1.5B+0% y/y | $0.79+3% y/y |
| May 6, 2020 Wed | 7:16 ambefore market open | Mar 31, 2020 | $1.5B+5% y/y | $0.88+35% y/y |
| Feb 13, 2020 Thu | 7:06 ambefore market open | Dec 31, 2019 | $1.7B+7% y/y | $0.80+13% y/y |
| Nov 7, 2019 Thu | 7:28 ambefore market open | Sep 30, 2019 | $1.6B+7% y/y | $0.90+27% y/y |
| Aug 6, 2019 Tue | 7:04 ambefore market open | Jun 30, 2019 | $1.5B+9% y/y | $0.77−3% y/y |
| May 2, 2019 Thu | 7:05 ambefore market open | Mar 31, 2019 | $1.5B+7% y/y | $0.65−10% y/y |
| Feb 14, 2019 Thu | 7:39 ambefore market open | Dec 31, 2018 | $1.6B+7% y/y | $0.71+344% y/y |
| Nov 1, 2018 Thu | 7:04 ambefore market open | Sep 30, 2018 | $1.5B+10% y/y | $0.71+16% y/y |
| Aug 2, 2018 Thu | 7:14 ambefore market open | Jun 30, 2018 | $1.4B+12% y/y | $0.79+58% y/y |
| May 2, 2018 Wed | 7:03 ambefore market open | Mar 31, 2018 | $1.4B+11% y/y | $0.72+50% y/y |
| Feb 15, 2018 Thu | 7:04 ambefore market open | Dec 31, 2017 | $1.5B+14% y/y | $0.16−48% y/y |
| Nov 2, 2017 Thu | 7:03 ambefore market open | Oct 1, 2017 | $1.3B+9% y/y | $0.61+27% y/y |
| Aug 8, 2017 Tue | 7:02 ambefore market open | Jul 2, 2017 | $1.3B+5% y/y | $0.50+11% y/y |
| May 4, 2017 Thu | 7:02 ambefore market open | Apr 2, 2017 | $1.2B+6% y/y | $0.48+17% y/y |
| Feb 16, 2017 Thu | 7:02 ambefore market open | Dec 31, 2016 | $1.3B+0% y/y | $0.31+675% y/y |
| Nov 2, 2016 Wed | 7:03 ambefore market open | Oct 2, 2016 | $1.2B+2% y/y | $0.48+26% y/y |
| Aug 3, 2016 Wed | 7:04 ambefore market open | Jul 3, 2016 | $1.2B+3% y/y | $0.45 |
| May 4, 2016 Wed | 7:01 ambefore market open | Apr 3, 2016 | $1.2B+5% y/y | $0.41+24% y/y |
| Feb 16, 2016 Tue | 7:03 ambefore market open | Dec 31, 2015 | $1.3B−3% y/y | $0.04−84% y/y |
| Nov 3, 2015 Tue | 7:02 ambefore market open | Sep 27, 2015 | $1.2B+0% y/y | $0.38+15% y/y |
| Jul 10, 2015 Fri | 4:31 pmafter market close | Jun 28, 2015 | $1.2B+1% y/y | −$0.07 |
| May 5, 2015 Tue | 7:02 ambefore market open | Mar 29, 2015 | $1.1B+0% y/y | $0.33+6% y/y |
| Feb 11, 2015 Wed | 7:04 ambefore market open | Dec 31, 2014 | $1.3B+5% y/y | $0.25+19% y/y |
| Nov 4, 2014 Tue | 7:03 ambefore market open | Sep 28, 2014 | $1.2B+10% y/y | $0.33+27% y/y |
| Aug 5, 2014 Tue | 7:09 ambefore market open | Jun 29, 2014 | $1.2B+4% y/y | $0.27+4% y/y |
| May 6, 2014 Tue | 7:06 ambefore market open | Mar 30, 2014 | $1.1B+1% y/y | $0.31+11% y/y |
| Feb 11, 2014 Tue | 7:08 ambefore market open | Dec 31, 2013 | $1.3B+7% y/y | $0.21 |
| Nov 5, 2013 Tue | 7:07 ambefore market open | Sep 29, 2013 | $1.1B+8% y/y | $0.26−19% y/y |
| Aug 6, 2013 Tue | 7:16 ambefore market open | Jun 30, 2013 | $1.1B+2% y/y | $0.26−26% y/y |
| Apr 30, 2013 Tue | 7:06 ambefore market open | Mar 31, 2013 | $1.1B+4% y/y | $0.28+27% y/y |
Show all 54 reports since 2013Show fewer
How we count
Report date and time — when the company filed its results press release with the SEC (Form 8-K, Item 2.02); the regular session runs 9:30 am – 4:00 pm ET. Companies that file the 8-K late in the evening publish the release the next morning: the date is that morning, before market open, and the evening filing time is not shown. Revenue and diluted EPS — the company’s XBRL filings, EPS adjusted for stock splits; ≈ — fourth quarter derived as full year minus three quarters. Source: SEC EDGAR.
Zoetis: 15-year financials
| 2025 | 9,467 | 2,673 | 2,283 |
| 2024 | 9,256 | 2,486 | 2,298 |
| 2023 | 8,544 | 2,344 | 1,621 |
| 2022 | 8,080 | 2,114 | 1,326 |
| 2021 | 7,776 | 2,037 | 1,736 |
| 2020 | 6,675 | 1,638 | 1,673 |
| 2019 | 6,260 | 1,500 | 1,335 |
| 2018 | 5,825 | 1,428 | 1,452 |
| 2017 | 5,307 | 864 | 1,122 |
| 2016 | 4,888 | 821 | 497 |
| 2015 | 4,765 | 339 | 440 |
| 2014 | 4,785 | 583 | 446 |
| 2013 | 4,561 | 504 | 497 |
| 2012 | 4,336 | 436 | 328 |
| 2011 | 4,233 | 245 | 362 |
Show all 15 yearsShow fewer
$ millions, annual 10-K reports on SEC EDGAR (US GAAP)*.
How we calculate
Figures are annual report lines; if a year was later restated (discontinued operations, mergers), we use the latest filing that shows it. Free cash flow is operating cash flow minus capital expenditures; dividends are cash paid to common shareholders during the year. “—” means the line isn’t in the filing.
Shareholders’ equity at Jun 30, 2026: $3.1B (21% of total assets). Compare with other S&P 500 companies →
Included in screener lists: S&P 500 companies with revenue growth 10 years in a row · S&P 500 companies that paid dividends 10 years without a gap
Zoetis (ZTS) earnings: FAQ
When is ZTS's next earnings date?
We have not yet seen an announcement of the date from Zoetis (ZTS). Based on last year's report on Nov 4, 2025, the next report is expected around Nov 3, 2026.
What time does ZTS report earnings?
Zoetis usually reports before market open: its latest results release was filed with the SEC at 7:06 am ET on Aug 6, 2026.
When did ZTS last report earnings?
Zoetis reported Q2 2026 results on Aug 6, 2026.
Where can I find Zoetis's financial statements?
On SEC EDGAR: quarterly reports (10-Q), the annual report (10-K) and earnings releases (8-K). The “Verified” badge next to the chart links to ZTS's filings; this page breaks the latest report down in a Sankey chart.
What was ZTS's net income in Q2 2026?
Zoetis reported net income of $691M for Q2 2026 (−4.8% year over year), under US GAAP.
How has Zoetis's revenue changed since 2011?
Per its 10-K filings, revenue grew 2.2x: $4,233M in 2011 and $9,467M in 2025. The latest year is the highest in the table. Year-by-year figures are in the table above.
New to earnings reports? Start with how to read an earnings report.
How this page was made: the figures come from the company's own report on SEC EDGAR; the summary and nuances were drafted by our model from that report — two independent automated readings of the release had to match, and every number in the text was checked against it. Figures checked against the filing on 10/16/2026. How we make the breakdowns · Report an error
More reports: A · Q3 FY2026 · ABBV · Q2 2026 · ABT · Q2 2026 · ALGN · Q2 2026 · AMGN · Q2 2026 · BAX · Q2 2026 · BDX · Q3 FY2026 · BIIB · Q2 2026 · BMY · Q2 2026 · BSX · Q2 2026 · all reports